Acción IMM IMMUTEP LIMITED
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Immutep Limited

Acciones

IMM

AU000000IMM6

Mercado cerrado - Australian S.E.
Otros sitios de cotización
 08:10:43 01/05/2024 		Varia. Cinco días. Varia. 1 de enero.
0,42 AUD -2,33 % Gráfico intradía de Immutep Limited +9,09 % +21,74 %
30/04 IMMUTEP LIMITED : El Canaccord Genuity continua con un recomendación de compra ZM
24/04 Immutep muestra datos positivos en un ensayo para tratar cánceres escamosos de cabeza y cuello MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Immutep Quarterly Activities Report Q3 FY24
Immutep Shows Positive Data in Trial to Treat Squamous Cell Cancers in Head, Neck
Immutep Limited Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761
Immutep Limited Appoints Leading Research Institute to Conduct First-In-Human Phase I Study of IMP761
Wilsons - Adding Autoimmune to the indication list; Mtn Overweight, A$0.90 Tgt (Analysts: Dr Melissa Benson and Dr Shane Storey)
Immutep Taps Center for Human Drug Research for IMP761 Human Clinical Trial
Immutep : Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP76
Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
Immutep Limited Receives Positive Feedback from the Spanish Medicines Agency for Upcoming Tacti-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
Australian Shares Tick Down as US Fed Chair Flags Likely Rate Cut Delay
Immutep Obtains Support from Spanish Health Agency for Efti Registrational Trial
Immutep : Corporate Presentation
Encouraging results for Immutep's cancer therapies
Ladenburg Thalmann - Next Is Dose Optimization for BC Program; Reiterate Buy, $8.30 PT (Analyst: Ahu Demir, PhD)
Wilsons - Dose it higher? Now an option; Mtn Overweight, A$0.90 Tgt (Analysts: Dr Melissa Benson and Dr Shane Storey)
Immutep Announces First Clinical Data from 90mg Dosing of Efti
Immutep Limited Announces First Clinical Data from 90Mg Dosing of Efti
Immutep Posts 59% Rise in H1 FY24 Revenue, Narrows Net Loss
Immutep Limited Reports Earnings Results for the Half Year Ended December 31, 2023
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción IMM
  4. Noticias Immutep Limited
  5. Otros idiomas